1 in 10 people over 50 is affected by AMD.​
‍
Age-related macular degeneration (AMD) is a leading cause of vision loss, yet early detection is often missed due to limited access to retinal specialists and slow, manual image analysis. Traditional screening methods can be time-consuming, resource-intensive, and hard to scale.

​​MediosHI AMD bridges this gap with on-the-edge, AI-powered analysis of fundus images, delivering rapid, point-of-care results. It enables early identification of AMD risk during routine screenings, supporting timely intervention and better patient outcomes.​​